Description
Arlevert (Cinnarizine, Dimenhydrinate) Tablets №50
Ingredients
Active ingredients: Cinnarizine, Dimenhydrinate
Mechanism of Action
Arlevert tablets combine the actions of Cinnarizine and Dimenhydrinate. Cinnarizine acts as a calcium channel blocker, reducing inner ear disturbances associated with vestibular disorders. Dimenhydrinate helps prevent nausea and vomiting, particularly in cases of motion sickness.
Pharmacological Properties
Through its calcium channel blocking properties, Cinnarizine stabilizes the inner ear function, alleviating symptoms of vertigo. Dimenhydrinate, an antihistamine, works by inhibiting the signals that trigger nausea and vomiting in the brain.
Indications for Use
Arlevert tablets are indicated for:
- Relief of symptoms associated with vestibular disorders
- Treatment of motion sickness
Contraindications
Do not use Arlevert tablets if:
- You are allergic to any of the ingredients
- You have Parkinson’s disease
- You are pregnant or breastfeeding
Side Effects
Common side effects of Arlevert tablets may include drowsiness and dry mouth. It is advisable to avoid activities requiring mental alertness, such as driving or operating machinery, until you are aware of how the medication affects you.
Usage Instructions
Recommended dosage: The usual dose is 1-2 tablets taken three times a day. Take the tablets with a glass of water, preferably with meals to reduce the risk of stomach upset.
Benefits Compared to Analogues
Arlevert tablets provide a comprehensive solution for managing symptoms of vestibular disorders and motion sickness. The dual action of Cinnarizine and Dimenhydrinate offers effective relief while minimizing common side effects associated with similar medications.
Suitable Patient Groups
Arlevert tablets are suitable for adults and adolescents. Consult a healthcare provider for appropriate dosing in children, elderly individuals, or patients with specific medical conditions.
Storage and Shelf Life
Store Arlevert tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product if it has expired.
Packaging Description
Arlevert tablets are available in a package containing 50 tablets. Each tablet is film-coated for easy swallowing and protection of the active ingredients.
Clinical Evidence and Proven Effectiveness
Studies have demonstrated the efficacy of the Cinnarizine and Dimenhydrinate combination in Arlevert tablets for managing symptoms of vertigo and motion sickness. Cinnarizine’s role as a calcium channel blocker and Dimenhydrinate’s antiemetic properties contribute to the therapeutic benefits observed in clinical trials.
